Acquiring Company
Blueprint Medicines Corporation
Acquired Company
Bristol Myers Squibb
CambridgePrincetonContent And PublishingMedia And EntertainmentHealth CareScience And EngineeringManufacturingBiotechnologyProfessional ServicesHealth CareMedicalTherapeuticsPharmaceuticalLegalBiopharmaLaw EnforcementDescription
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the company has successfully completed its previously announced acquisition of Lengo Therapeutics and lead compound LNG-451, a potential best-in-class oral precision therapy in development for the treatment of non-small cell lung cancer (NSCLC) in patients with EGFR exon 20 insertion mutations. An investigational new drug (IND) application for LNG-451 was submitted to the U.S. Food and Drug Administration (FDA) by Lengo Therapeutics in December 2021.
Quick answer
Blueprint Medicines Corporation is acquiring Bristol Myers Squibb, announced December 30, 2021. Blueprint Medicines Corporation is based in Cambridge, Massachusetts, United States.
- How much did Blueprint Medicines Corporation pay for Bristol Myers Squibb?
- The deal value was not disclosed.
- What does Blueprint Medicines Corporation do?
- Blueprint Medicines Corporation is a biotechnology company dedicated to developing targeted therapies for genomically defined cancers.
- Where are Blueprint Medicines Corporation and Bristol Myers Squibb based?
- Blueprint Medicines Corporation is based in Cambridge, Massachusetts, United States. Bristol Myers Squibb is based in Princeton, New Jersey, United States.
Source: Fundz verified event record.
Other recent acquisitions in Content And Publishing and Media And Entertainment
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Intellia Therapeutics Announces Acquisition Of Rewrite Therapeutics (February 3, 2022)
- Asymchem Acquires Snapdragon Chemistry (February 11, 2022)
- Element Biosciences Closes Acquisition Of Loop Genomics (February 8, 2022)
- Waters Acquires Charge Detection Mass Spectrometry Technology To Broaden Its Application In Cell And Gene Therapy (February 1, 2022)
- Riverside Partners' Portfolio Company Loftware Acquires Prisym Id (January 11, 2022)
- Loftware Acquires Prisym Id, Expands Enterprise Labeling Solutions For Medical Device And Pharmaceutical Companies (January 11, 2022)
Who to call at Blueprint Medicines Corporation, and when
When Blueprint Medicines Corporation changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Blueprint Medicines Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Blueprint Medicines Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Blueprint Medicines Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Blueprint Medicines Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Bristol Myers Squibb?
Bristol Myers Squibb was acquired by Blueprint Medicines Corporation, based in Cambridge. The deal was reported on December 30, 2021. Blueprint Medicines Corporation is a biotechnology company dedicated to developing targeted therapies for genomically defined cancers. The company focuses on precision medicine and innovative cancer treatment strategies. Blueprint Medicines Corporation is privately held and operates in Content And Publishing.
When did Blueprint Medicines Corporation acquire Bristol Myers Squibb?
Blueprint Medicines Corporation's acquisition of Bristol Myers Squibb was reported on December 30, 2021. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bristol Myers Squibb do?
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. It is publicly traded (BMY), operating in Manufacturing, and is based in Princeton.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.